Phase 1 Study of BXQ-350 in Adult Patients With Advanced Solid Tumors
Clinical trial NCT02859857 · COMPLETED
Trial details
- NCT number
- NCT02859857
- Sponsor
- Bexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2019-06-17
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.